3.4382.11% ( -0.074 )
Delay Closed: Nov 16, 16:08:00Wiki
About
The investment objective of the CSOP China Healthcare Disruption Index ETF (the Sub-Fund) is to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Index, namely, Solactive China Healthcare Disruption Index (the Index).
- Name
- CSOP HEALTHCARE
- Index tracked
- Hang Seng Biotech TR HKD
- Type
- Equity
- Expense ratio
- 0.99%
- Management fee
- 0.99%
- Dividend policy
- Annually
- NAV
- HKD 3.5137 (11/12/2026)
- Issued units
- 256.86M (11/13/2026)
- Listing date
- Jul 21, 2021
- Sponsor
- CSOP Asset Management Limited
- Custodian
- --
ETF Documents
Last updatedType
10/09/2026Factsheet
05/08/2026Annual Report
09/07/2026Semi Annual Report
10/09/2026Prospectus
